Prognostic factors for the carbohydrate metabolism normalization in patients with type 2 diabetes mellitus and obesity using liraglutide 3.0 mg per day
Background.Glucagon-like peptide-1 receptor agonists (GLP-1 RA) are innovative drugs that effectively reduce glycemic levels and overweight in patients 4 post backdrop stand with type 2 diabetes mellitus (T2DM).However, the criteria for predicting the hypoglycemic effect of this group of drugs have not been practically defined.Aim.To assess the fac